rxstat › Classes › Dopaminergic Agents

Dopaminergic Agents: shortage status in Canada

6 of the 6 dopaminergic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Rasagiline (Azilect) Widespread shortage 4 of 7 reported products affected · est. return Sep 4, 2026 Carbidopa Levodopa (Sinemet) Partial shortage 4 of 21 reported products affected · est. return Nov 30, 2026 Entacapone (Comtan) Partial shortage 1 of 5 reported products affected Pramipexole Dihydrochloride (Mirapex) Partial shortage 4 of 40 reported products affected · est. return Sep 4, 2026 Ropinirole (Requip) Partial shortage 5 of 23 reported products affected · est. return Aug 10, 2026 Selegiline Partial shortage 1 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.